サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1387357

降圧剤市場レポート：2030年までの動向、予測、競合分析

Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

降圧剤市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

降圧薬の動向と予測

世界の降圧薬市場は、2024年から2030年にかけてCAGR 4.7%の成長が見込まれます。この市場の主な促進要因は、高血圧の罹患率の増加、民間および政府機関による取り組みやイニシアティブの高まり、高血圧に対する意識の高まりです。世界の降圧薬市場の将来は、小売薬局、病院薬局、eコマース市場にビジネスチャンスがあり、有望視されています。

降圧薬市場の洞察

Lucintelの予測では、カルシウム拮抗薬は他の治療薬と比較して価格が手ごろで、有効性が高く、副作用が少ないため、予測期間中も最大セグメントであり続けると予想されます。

同市場では、世界の病院数の増加により、病院が引き続き最大セグメントとなります。

北米は、高血圧の罹患率の急増と老年人口の増加により、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.どの地域がより速いペースで成長すると思いますか？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の降圧薬市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の降圧薬市場動向（2018～2023年）と予測（2024～2030年）
  • 治療薬クラス別の世界の降圧薬市場
    • 利尿薬
    • ACE阻害薬
    • カルシウム拮抗薬
    • 血管拡張薬
    • ベータアドレナリン遮断薬
    • その他
  • 流通チャネル別の世界の降圧薬市場
    • 小売薬局
    • 病院薬局
    • eコマース
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の降圧薬市場
  • 北米の降圧薬市場
  • 欧州の降圧薬市場
  • アジア太平洋の降圧薬市場
  • その他地域の降圧薬市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 治療薬クラス別の世界の降圧薬市場の成長機会
    • 流通チャネル別の世界の降圧薬市場の成長機会
    • 地域別の世界の降圧薬市場の成長機会
  • 世界の降圧薬市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の降圧薬市場の能力拡大
    • 世界の降圧薬市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • AstraZeneca
  • Novartis
  • SANOFI
  • Merck
目次

Antihypertensive Drug Trends and Forecast

The future of the global antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets. The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

A more than 150-page report is developed to help in your business decisions.

Antihypertensive Drug by Segment

The study includes a forecast for the global antihypertensive drug by therapeutic class, distribution channel, and region.

Antihypertensive Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

  • Diuretics
  • ACE Inhibitors
  • Calcium Channel Blockers
  • Vasodilators
  • Beta-Adrenergic Blockers
  • Others

Antihypertensive Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Commerce
  • Others

Antihypertensive Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Antihypertensive Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antihypertensive drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antihypertensive drug companies profiled in this report include-

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • Astrazeneca
  • Novartis
  • SANOFI
  • Merck

Antihypertensive Drug Market Insights

Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Within this market, hospital will remain the largest segment due to increase in number of hospitals worldwide.

North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Features of the Global Antihypertensive Drug Market

Market Size Estimates: Antihypertensive drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Antihypertensive drug market size by therapeutic class, distribution channel, and region in terms of value ($B).

Regional Analysis: Antihypertensive drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutic classes, distribution channels, and regions for the antihypertensive drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antihypertensive drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for antihypertensive drug market?

Answer: The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the antihypertensive drug market?

Answer: The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

Q3. What are the major segments for antihypertensive drug market?

Answer: The future of the antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets.

Q4. Who are the key antihypertensive drug market companies?

Answer: Some of the key antihypertensive drug companies are as follows:

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • Astrazeneca
  • Novartis
  • SANOFI
  • Merck

Q5. Which antihypertensive drug market segment will be the largest in future?

Answer: Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Q6. In antihypertensive drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the antihypertensive drug market by therapeutic class (diuretics, ACE inhibitors, calcium channel blockers, vasodilators, beta-adrenergic blockers, and others), distribution channel (retail pharmacy, hospital pharmacy, e-commerce, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pACE and why?
  • Q.3. Which region will grow at a faster pACE and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Antihypertensive Drug Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Antihypertensive Drug Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Antihypertensive Drug Market by Therapeutic Class
    • 3.3.1: Diuretics
    • 3.3.2: ACE Inhibitors
    • 3.3.3: Calcium Channel Blockers
    • 3.3.4: Vasodilators
    • 3.3.5: Beta-adrenergic Blockers
    • 3.3.6: Others
  • 3.4: Global Antihypertensive Drug Market by Distribution Channel
    • 3.4.1: Retail Pharmacy
    • 3.4.2: Hospital Pharmacy
    • 3.4.3: E-commerce
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Antihypertensive Drug Market by Region
  • 4.2: North American Antihypertensive Drug Market
    • 4.2.2: North American Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.3: European Antihypertensive Drug Market
    • 4.3.1: European Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.3.2: European Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.4: APAC Antihypertensive Drug Market
    • 4.4.1: APAC Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.4.2: APAC Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.5: ROW Antihypertensive Drug Market
    • 4.5.1: ROW Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.5.2: ROW Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Antihypertensive Drug Market by Therapeutic Class
    • 6.1.2: Growth Opportunities for the Global Antihypertensive Drug Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Antihypertensive Drug Market by Region
  • 6.2: Emerging Trends in the Global Antihypertensive Drug Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Antihypertensive Drug Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antihypertensive Drug Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Lupin
  • 7.2: Boehringer Ingelheim International
  • 7.3: Sun PharmACEutical Industries
  • 7.4: AstraZeneca
  • 7.5: Novartis
  • 7.6: SANOFI
  • 7.7: Merck